Quantum Cyber N.V. Adjustments For Increase Decrease In Trade And Other Payables
Quantum Cyber N.V. (QUCY) reported Adjustments For Increase Decrease In Trade And Other Payables of -$603.12 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-26.
Financial Statements › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables · last filed 2025-09-26
- Quantum Cyber N.V. adjustments for increase decrease in trade and other payables for the quarter ending 2023-12-31 was $484.67K, a 74.21% decline year-over-year.
- Quantum Cyber N.V. adjustments for increase decrease in trade and other payables for the quarter ending 2023-09-30 was -$925.95K.
- Quantum Cyber N.V. adjustments for increase decrease in trade and other payables for the quarter ending 2023-06-30 was $1.55M, a 3161.96% increase year-over-year.
- Quantum Cyber N.V. adjustments for increase decrease in trade and other payables for the quarter ending 2023-03-31 was -$390.17K, a 691.79% decline year-over-year.
| Period end | Adjustments For Increase Decrease In Trade And Other Payables 3 month | Adjustments For Increase Decrease In Trade And Other Payables 6 month | Adjustments For Increase Decrease In Trade And Other Payables 9 month | Adjustments For Increase Decrease In Trade And Other Payables 12 month | Adjustments For Increase Decrease In Trade And Other Payables 12 month as first filed |
|---|---|---|---|---|---|
| 2025-06-30 | -$603.12K 6-K · filed 2025-09-26 | ||||
| 2024-12-31 | $84.61K 20-F · filed 2025-03-31 | ||||
| 2024-06-30 | $285.16K 6-K · filed 2025-09-26 | ||||
| 2023-12-31 | $484.67K derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | -$441.28K derived: sum of 2 quarters · filed 2025-03-31 | $1.11M derived: sum of 3 quarters · filed 2025-03-31 | $720.24K 20-F · filed 2025-03-31 | |
| 2023-09-30 | -$925.95K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-16 | $625.73K derived: sum of 2 quarters · filed 2024-10-18 | $235.57K 6-K · filed 2023-11-16 | $2.11M derived: sum of 4 quarters · filed 2025-03-31 | |
| 2023-06-30 | $1.55M derived: 6-K 6 month − 6-K 3 month · filed 2024-10-18 | $1.16M 6-K · filed 2024-10-18 | $3.04M derived: sum of 3 quarters · filed 2025-03-31 | $2.70M derived: sum of 4 quarters · filed 2025-03-31 | |
| 2023-03-31 | -$390.17K 6-K · filed 2023-05-16 | $1.49M derived: sum of 2 quarters · filed 2025-03-31 | $1.15M derived: sum of 3 quarters · filed 2025-03-31 | $1.19M derived: sum of 4 quarters · filed 2025-03-31 | |
| 2022-12-31 | $1.88M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | $1.54M derived: sum of 2 quarters · filed 2025-03-31 | $1.58M derived: sum of 3 quarters · filed 2025-03-31 | $1.65M 20-F · filed 2025-03-31 | $1.82M 20-F · filed 2023-04-07 |
| 2022-09-30 | -$342.33K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-16 | -$294.76K derived: sum of 2 quarters · filed 2023-11-16 | -$228.83K 6-K · filed 2023-11-16 | ||
| 2022-06-30 | $47.57K derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15 | $113.50K 6-K · filed 2023-08-15 | |||
| 2022-03-31 | $65.93K 6-K · filed 2023-05-16 | ||||
| 2021-12-31 | $659.64K 20-F · filed 2024-04-09 | $670.73K 20-F · filed 2022-05-03 | |||
| 2021-06-30 | $23.85K 6-K · filed 2022-09-07 | ||||
| 2020-12-31 | $160.48K 20-F · filed 2023-04-07 | ||||
| 2019-12-31 | $87.42K 20-F · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |